FI112211B - Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet Download PDF

Info

Publication number
FI112211B
FI112211B FI935318A FI935318A FI112211B FI 112211 B FI112211 B FI 112211B FI 935318 A FI935318 A FI 935318A FI 935318 A FI935318 A FI 935318A FI 112211 B FI112211 B FI 112211B
Authority
FI
Finland
Prior art keywords
formula
compound
amino
group
och
Prior art date
Application number
FI935318A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI935318A (fi
FI935318A0 (fi
Inventor
Soth Samreth
Patrice Renaut
Luc Lebreton
Patrick Dutartre
Philippe Derrepas
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of FI935318A0 publication Critical patent/FI935318A0/fi
Publication of FI935318A publication Critical patent/FI935318A/fi
Application granted granted Critical
Publication of FI112211B publication Critical patent/FI112211B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI935318A 1992-12-02 1993-11-29 Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet FI112211B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214517A FR2698628B1 (fr) 1992-12-02 1992-12-02 Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR9214517 1992-12-02

Publications (3)

Publication Number Publication Date
FI935318A0 FI935318A0 (fi) 1993-11-29
FI935318A FI935318A (fi) 1994-06-03
FI112211B true FI112211B (fi) 2003-11-14

Family

ID=9436147

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935318A FI112211B (fi) 1992-12-02 1993-11-29 Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet

Country Status (24)

Country Link
US (1) US5476870A (ja)
EP (1) EP0600762B1 (ja)
JP (1) JP2945261B2 (ja)
KR (1) KR100187328B1 (ja)
CN (1) CN1045431C (ja)
AT (1) ATE140215T1 (ja)
AU (1) AU664124B2 (ja)
CA (1) CA2110437C (ja)
CZ (1) CZ284958B6 (ja)
DE (1) DE69303583T2 (ja)
DK (1) DK0600762T3 (ja)
ES (1) ES2092263T3 (ja)
FI (1) FI112211B (ja)
FR (1) FR2698628B1 (ja)
GR (1) GR3021269T3 (ja)
HK (1) HK1000467A1 (ja)
HU (1) HU218908B (ja)
NO (1) NO180483C (ja)
NZ (1) NZ250330A (ja)
RU (1) RU2114823C1 (ja)
SK (1) SK280286B6 (ja)
TW (1) TW311132B (ja)
UA (1) UA39920C2 (ja)
ZA (1) ZA938821B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996024579A1 (fr) * 1995-02-10 1996-08-15 Fournier Industrie Et Sante Analogues de la 15-deoxyspergualine, leur utilisation en therapeutique et leur procede de preparation
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
DE19728436A1 (de) * 1997-07-03 1999-01-07 Niels Franke Niedrigdosierte 15-Desoxyspergualin-Präparate
AU764144B2 (en) * 1998-08-28 2003-08-14 Gryphon Therapeutics, Inc. Polyamide chains of precise length, methods to manufacture them and their conjugates
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen
AU2005237764B2 (en) * 2004-05-05 2011-11-24 Silence Therapeutics Gmbh Lipids, lipid complexes and use thereof
US8852472B2 (en) 2004-12-27 2014-10-07 Silence Therapeutics Gmbh Coated lipid complexes and their use
EP2269980A4 (de) 2008-12-24 2011-05-18 Vertex Closed Joint Stock Company Creatinamide, verfahren zu ihrer herstellung und wirkstoff zur ausführung einer neuroprotektiven aktion
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
FR2963238B1 (fr) * 2010-07-29 2012-12-28 Fournier Lab Sa Derives de 15-desoxyspergualine pour le traitement et/ou la prevention des maladies inflammatoires oculaires
KR20130099926A (ko) * 2010-07-29 2013-09-06 라보라뚜와르 푸르니에 에스.아. 염증성 눈질환의 치료/예방용 화합물
KR101695730B1 (ko) 2015-03-10 2017-01-12 하경훈 마늘꼭지 절단기의 절단장치
FR3050455B1 (fr) * 2016-04-26 2019-06-14 Temisis Derives amides des acides polycafeoylquiniques, procede de preparation et utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
DE3770680D1 (de) * 1986-04-04 1991-07-18 Microbial Chem Res Found Spergualinaehnliche verbindungen und ihr herstellungsverfahren.
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions

Also Published As

Publication number Publication date
HK1000467A1 (en) 1998-03-27
AU5188393A (en) 1994-06-16
NO934338L (no) 1994-06-03
DE69303583D1 (de) 1996-08-14
NZ250330A (en) 1995-06-27
KR100187328B1 (ko) 1999-05-15
JPH06293728A (ja) 1994-10-21
RU2114823C1 (ru) 1998-07-10
EP0600762B1 (fr) 1996-07-10
CZ284958B6 (cs) 1999-04-14
EP0600762A1 (fr) 1994-06-08
DK0600762T3 (da) 1996-11-11
FR2698628A1 (fr) 1994-06-03
SK280286B6 (sk) 1999-11-08
HU218908B (hu) 2000-12-28
NO180483B (no) 1997-01-20
FI935318A (fi) 1994-06-03
GR3021269T3 (en) 1997-01-31
NO180483C (no) 1997-04-30
FI935318A0 (fi) 1993-11-29
CA2110437C (en) 1999-04-13
ATE140215T1 (de) 1996-07-15
CN1045431C (zh) 1999-10-06
JP2945261B2 (ja) 1999-09-06
US5476870A (en) 1995-12-19
TW311132B (ja) 1997-07-21
SK135793A3 (en) 1994-06-08
CZ262293A3 (en) 1994-06-15
CA2110437A1 (en) 1994-06-03
NO934338D0 (no) 1993-11-30
FR2698628B1 (fr) 1995-02-17
ZA938821B (en) 1994-06-30
CN1095709A (zh) 1994-11-30
UA39920C2 (uk) 2001-07-16
KR940014435A (ko) 1994-07-18
DE69303583T2 (de) 1996-11-21
HU9303406D0 (en) 1994-03-28
AU664124B2 (en) 1995-11-02
ES2092263T3 (es) 1996-11-16
HUT65782A (en) 1994-07-28

Similar Documents

Publication Publication Date Title
FI112211B (fi) Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet
US20040063725A1 (en) Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use
AU726376B2 (en) Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
CZ29996A3 (en) Amidine derivatives with activities of nitrogen oxide sythetase
RU2113431C1 (ru) Аналоги 15-дезоксиспергуалина, способ их получения, способ получения промежуточных соединений (варианты), аминозащищенные соединения в качестве промежуточных соединений и фармацевтическая композиция на основе аналогов 15-дезоксиспергуалина
JP2860778B2 (ja) 15−デオキシスペルグアリン類似体、その製造方法および治療薬
US6258976B1 (en) Process for the preparation of polyamines and polyamine derivatives
AU717834B2 (en) Preparation of optically active (S)-(-) and (R)-(+)- deoxyspergualin and novel intermediates thereof

Legal Events

Date Code Title Description
MA Patent expired